DelveInsight's Indolent Lymphoma Market Insights report includes a comprehensive understanding of current treatment practices ...
Authors of a recent editorial appearing in the Journal of the National Cancer Institute say opening clinical trials in follicular lymphoma (FL) to less than ideal candidates—and more like those seen ...
DelveInsight’s, “Mantle Cell Lymphoma- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and ...
The young mother-to-be was 20 weeks pregnant when she found out she had stage four, aggressive lymphoma. Months later, on ...
In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...
In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de ...
Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced a beneficial ...
Cancer treatments have evolved, improving survival rates and quality of life, challenging the notion of cancer as a death ...
Everyday, more than 500 Central New Yorks will come to the Upstate Cancer Center or another location to get chemo, radiation ...
An event aimed at spreading light and hope for patients and families dealing with the impacts of blood cancer is set to ...
Hope illuminated the night sky at Siena College during the Lymphoma and Leukemia Society's annual Light the Night ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback